Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04426500 · ClinicalTrials.gov registry record · Phase 3
Use of Perioperative Pain Blocks In Urological Surgery
A Phase 3 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
NCT04426500 is a Phase 3 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 148 participants.
The verdict
NCT04426500, a Phase 3 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
Study Summary
The study team aims to prospectively compare Placebo (local administration), ultrasound-guided transversus abdominis plane (UTAP) blocks, and laparoscopic-guided transversus abdominis plane (LTAP) blocks in patients undergoing robotic surgery of the prostate and kidney. The study team expects to be able to equally efficiently administer the blocks using direct visualization and ultrasound guidance. The study team expects that a negative result would obviate the need for longer operative time by eliminating the need for the separate ultrasound guided block while a positive result would demonstrate the increased utility of preoperative ultrasound blocks in managing postoperative pain.
Interventions
- DRUG Bupivacain
- DRUG Ultrasound-guided transversus abdominus plane block
- DRUG Laparoscopic-guided transversus abdominus plane block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2019-11-11 |
| Est. Completion | 2021-02-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04426500
The ClinicalTrials.gov registry entry for NCT04426500 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacain is the first listed.
NCT04426500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04426500 about?
NCT04426500 is a clinical study titled "Use of Perioperative Pain Blocks In Urological Surgery". The study team aims to prospectively compare Placebo (local administration), ultrasound-guided transversus abdominis plane (UTAP) blocks, and laparoscopic-guided transversus abdominis plane (LTAP) blocks in patients undergoing robotic surgery of the prostate and kidney. The study team expects to be ...
What is the current status of trial NCT04426500?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2019-11-11. Estimated completion is 2021-02-13.
What interventions are being tested in trial NCT04426500?
The interventions under investigation include: Bupivacain (DRUG), Ultrasound-guided transversus abdominus plane block (DRUG), Laparoscopic-guided transversus abdominus plane block (DRUG).
Who is sponsoring clinical trial NCT04426500?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.